Kinetic Therapy: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Kinetic Therapy
Largest movements
- Deferred charges and accrued income -€32,793
down €32,793 (-99.6%), from €32,929 to €135
- Receivables within one year -€13,210
down €13,210 (-95.4%), from €13,853 to €644
- Cash -€5,152
down €5,152 (-99.2%), from €5,194 to €42
mainly Trade debts (-€17,819) and Net result for the year (-€17,693)
- Trade debts -€17,819
down €17,819 (-99.2%), from €17,954 to €135
- Profit (loss) carried forward -€17,693
down €17,693 (-50.9%), from -€34,751 to -€52,443
- Other debts -€8,476
down €8,476 (-15.3%), from €55,523 to €47,048
- Accrued charges and deferred income -€7,227
no longer reported in 2025 (was €7,227)
- Gross operating margin -€24,951
down €24,951, from €8,462 to -€16,489
- Other operating charges +€411
up €411 (+107%), from €384 to €796
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €52,507 | €1,014 | -€51,493 | -98.1% |
| Fixed assets | 21/28 | €531 | €193 | -€339 | -63.8% |
| Tangible fixed assets | 22/27 | €531 | €193 | -€339 | -63.8% |
| Plant, machinery and equipment | 23 | €531 | €193 | -€339 | -63.8% |
| Current assets | 29/58 | €51,976 | €821 | -€51,155 | -98.4% |
| Amounts receivable within one year | 40/41 | €13,853 | €644 | -€13,210 | -95.4% |
| Trade receivables | 40 | €13,853 | €644 | -€13,210 | -95.4% |
| Cash at bank and in hand | 54/58 | €5,194 | €42 | -€5,152 | -99.2% |
| Deferred charges and accrued income | 490/1 | €32,929 | €135 | -€32,793 | -99.6% |
| Total equity and liabilities | 10/49 | €52,507 | €1,014 | -€51,493 | -98.1% |
| Equity | 10/15 | -€28,551 | -€46,243 | -€17,693 | -62.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€34,751 | -€52,443 | -€17,693 | -50.9% |
| Amounts payable | 17/49 | €81,058 | €47,257 | -€33,801 | -41.7% |
| Amounts payable within one year | 42/48 | €73,831 | €47,257 | -€26,574 | -36.0% |
| Trade debts | 44 | €17,954 | €135 | -€17,819 | -99.2% |
| Suppliers | 440/4 | €17,954 | €135 | -€17,819 | -99.2% |
| Taxes, remuneration and social security | 45 | €353 | €74 | -€279 | -79.0% |
| Taxes | 450/3 | €353 | €74 | -€279 | -79.0% |
| Other amounts payable | 47/48 | €55,523 | €47,048 | -€8,476 | -15.3% |
| Accrued charges and deferred income | 492/3 | €7,227 | - | -€7,227 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €339 | €339 | = | 0.0% |
| Other operating charges | 640/8 | €384 | €796 | +€411 | +107% |
| Gross operating margin | 9900 | €8,462 | -€16,489 | -€24,951 | |
| Operating profit (loss) | 9901 | €7,738 | -€17,624 | -€25,362 | |
| Financial charges | 65/66B | €75 | €69 | -€6 | -8.5% |
| Recurring financial charges | 65 | €75 | €69 | -€6 | -8.5% |
| Profit (loss) for the period before taxes | 9903 | €7,663 | -€17,693 | -€25,356 | |
| Profit (loss) for the period | 9904 | €7,663 | -€17,693 | -€25,356 | |
| Profit (loss) for the period to be appropriated | 9905 | €7,663 | -€17,693 | -€25,356 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.